Ribosome biogenesis is a therapeutic vulnerability in paediatric neuroblastoma
Ribosome biogenesis is a therapeutic vulnerability in paediatric neuroblastoma
About this item
Full title
Author / Creator
Publisher
United States: Cold Spring Harbor Laboratory
Journal title
Language
English
Formats
Publication information
Publisher
United States: Cold Spring Harbor Laboratory
Subjects
More information
Scope and Contents
Contents
Neuroblastoma is a heterogeneous malignant paediatric tumor with prognosis depending on patient age and disease stage. Current treatment strategies rely on four key diagnostic criteria: age, histological stage,
gene status, and genomic profile. It has been reported that MYC oncogenic activity depends on ribosome biogenesis, whose hyperactivation...
Alternative Titles
Full title
Ribosome biogenesis is a therapeutic vulnerability in paediatric neuroblastoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11974838
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11974838
Other Identifiers
ISSN
2692-8205
E-ISSN
2692-8205
DOI
10.1101/2025.03.26.645392
